Peer Review reports
From: Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses
Original Submission | ||
---|---|---|
4 Mar 2020 | Submitted | Original manuscript |
1 Apr 2020 | Author responded | Author comments - Toshihiko Matsumoto |
Resubmission - Version 2 | ||
1 Apr 2020 | Submitted | Manuscript version 2 |
6 Apr 2020 | Reviewed | Reviewer Report - Bianca Mostert |
29 Apr 2020 | Reviewed | Reviewer Report |
17 May 2020 | Author responded | Author comments - Toshihiko Matsumoto |
Resubmission - Version 3 | ||
17 May 2020 | Submitted | Manuscript version 3 |
22 May 2020 | Author responded | Author comments - Toshihiko Matsumoto |
Resubmission - Version 4 | ||
22 May 2020 | Submitted | Manuscript version 4 |
27 May 2020 | Author responded | Author comments - Toshihiko Matsumoto |
Resubmission - Version 5 | ||
27 May 2020 | Submitted | Manuscript version 5 |
4 Jun 2020 | Author responded | Author comments - Toshihiko Matsumoto |
Resubmission - Version 6 | ||
4 Jun 2020 | Submitted | Manuscript version 6 |
Publishing | ||
13 Jul 2020 | Editorially accepted | |
22 Jul 2020 | Article published | 10.1186/s12885-020-07176-7 |
You can find further information about peer review here.